Literature DB >> 12181566

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.

Maria Lindskog1, Per Svenningsson, Laura Pozzi, Yong Kim, Allen A Fienberg, James A Bibb, Bertil B Fredholm, Angus C Nairn, Paul Greengard, Gilberto Fisone.   

Abstract

Caffeine has been imbibed since ancient times in tea and coffee, and more recently in colas. Caffeine owes its psychostimulant action to a blockade of adenosine A(2A) receptors, but little is known about its intracellular mechanism of action. Here we show that the stimulatory effect of caffeine on motor activity in mice was greatly reduced following genetic deletion of DARPP-32 (dopamine- and cyclic AMP-regulated phosphoprotein of relative molecular mass 32,000). Results virtually identical to those seen with caffeine were obtained with the selective A(2A) antagonist SCH 58261. The depressant effect of the A(2A) receptor agonist, CGS 21680, on motor activity was also greatly attenuated in DARPP-32 knockout mice. In support of a role for DARPP-32 in the action of caffeine, we found that, in striata of intact mice, caffeine increased the state of phosphorylation of DARPP-32 at Thr 75. Caffeine increased Thr 75 phosphorylation through inhibition of PP-2A-catalysed dephosphorylation, rather than through stimulation of cyclin-dependent kinase 5 (Cdk5)-catalysed phosphorylation, of this residue. Together, these studies demonstrate the involvement of DARPP-32 and its phosphorylation/dephosphorylation in the stimulant action of caffeine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181566     DOI: 10.1038/nature00817

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

1.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  Microarray and real-time PCR analyses of gene expression in the honeybee brain following caffeine treatment.

Authors:  Robert Kucharski; Ryszard Maleszka
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.

Authors:  Katerina Antoniou; Zeta Papadopoulou-Daifoti; Thomas Hyphantis; Georgia Papathanasiou; Efstathios Bekris; Marios Marselos; Leigh Panlilio; Christa E Müller; Steven R Goldberg; Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

4.  Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.

Authors:  Francisco Ciruela; Vicent Casadó; Ricardo J Rodrigues; Rafael Luján; Javier Burgueño; Meritxell Canals; Janusz Borycz; Nelson Rebola; Steven R Goldberg; Josefa Mallol; Antonio Cortés; Enric I Canela; Juan F López-Giménez; Graeme Milligan; Carme Lluis; Rodrigo A Cunha; Sergi Ferré; Rafael Franco
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

Review 5.  Adenosine A2A receptors and basal ganglia physiology.

Authors:  S N Schiffmann; G Fisone; R Moresco; R A Cunha; S Ferré
Journal:  Prog Neurobiol       Date:  2007-06-26       Impact factor: 11.685

6.  A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.

Authors:  Camron D Bryant; Melissa E Graham; Margaret G Distler; Michaelanne B Munoz; Dongdong Li; Paul Vezina; Greta Sokoloff; Abraham A Palmer
Journal:  Psychopharmacology (Berl)       Date:  2008-12-03       Impact factor: 4.530

Review 7.  Popular sports supplements and ergogenic aids.

Authors:  Mark Juhn
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 8.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

9.  FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity.

Authors:  Marc Flajolet; Zhongfeng Wang; Marie Futter; Weixing Shen; Nina Nuangchamnong; Jacob Bendor; Iwona Wallach; Angus C Nairn; D James Surmeier; Paul Greengard
Journal:  Nat Neurosci       Date:  2008-10-26       Impact factor: 24.884

10.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.